Treatment of Vitiligo With UV-B Radiation vs Topical Psoralen Plus UV-A

Archives of Dermatology

Volumn 133, Issue 12, 1997, Pages 1525-1528

  Westerhof, Wiete ^a,b   Nieuweboer Krobotova, Ludmila ^a  

^a Dutch Institute for Pigmentary Disorders (SNIP)   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PSORALEN;

ADULT; ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUVA; RADIATION DOSE; RADIOSENSITIVITY; SKIN PIGMENTATION; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET B RADIATION; VITILIGO;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORALENS; PUVA THERAPY; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; TIME FACTORS; ULTRAVIOLET THERAPY; VITILIGO;

EID: 0142170835     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1997.03890480045006     Document Type: Article

References (13)

1. Ortonne JP, Mosher DB, Fitzpatrick TB. Vitiligo and Other Hypomelanoses of Hair and Skin. New York, NY: Plenum Press; 1983:256.
2. Lowe NJ, Weingarten D, Bourget T, Moy LS. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen. J Am Acad Dermatol. 1986;14:754-760.
3. Neild VS, Scott LV. Plasma levels of 8-methoxypsoralen in psoriatic patients receiving topical 8-methoxypsoralen. Br J Dermatol. 1982;106:199-203.
4. De Rie MA, van Eendenburg JP, Versnick AC, Stolk LM, Bos JD, Westerhof W. A new psoralen-containing gel for topical PUVA therapy: development and treatment results in patients with palmoplantar and plaque-type psoriasis and hyperkeratotic eczema. Br J Dermatol. 1995;132:964-969.
5. van Weelden H, De la Faille HB, Young E, van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol. 1988;119:11-19.
6. van Weelden H, De la Faille HB, Young E, van der Leun JC. Comparison of narrow-band UV-B phototherapy and PUVA photochemotherapy in the treatment of psoriasis. Acta Derm Venereol. 1990;70:212-215.
7. Köster W, Wiskemann A. Phototherapie mit UV-B bei Vitiligo. Z Hautkr. 1990; 65:1022-1029.
8. Buckley DA, Rogers S. Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo. Clin Exp Dermatol. 1996;21:43-45.
9. Haider RM, Battle E, Smith EM. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo. Arch Dermatol. 1995;131:734-735.
10. Gupta AK, Anderson TF. Psoralen photochemotherapy. JAm Acad Dermatol. 1987; 17:703-734.
11. Stern RS, Thibodeau LA, Kleinerman RA, et al. Risk of cutaneous carcinoma in patients treated with oral methoxalen photochemotherapy for psoriasis. N Engl J Med. 1987;30:809-813.
12. Johnson EB, Mandell G, Daniels F. Melanin and cellular reactions to ultraviolet radiation. Nature. 1992;235:147-149.
13. Calanchini-Postizzi E, Frenk E. Long-term actinic damage in sun-exposed vitiligo and normally pigmented skin. Dermatologica. 1987;174:266-271.